BioVentrix, Inc. (BVXX)

BioVentrix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	-0.75	-0.75	-0.93
Debt / EBITDA Ratio	-1.43	-1.43	-1.34
Debt / FCF Ratio	-1.53	-1.53	-1.73
Net Debt / Equity Ratio	-0.59	-0.59	-0.41
Net Debt / EBITDA Ratio	-1.14	-1.14	-0.59
Net Debt / FCF Ratio	-1.22	-1.22	-0.76
Quick Ratio	0.13	0.13	0.34
Interest Coverage	-4.51	-4.51	-11.42
Return on Equity (ROE)	64.08%	64.08%	76.42%
Return on Assets (ROA)	-298.49%	-298.49%	-117.43%
Return on Capital Employed (ROCE)	56.48%	56.48%	79.52%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).